BB Biotech AG
Latest statistics and disclosures from Bb Biotech Ag's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Ionis Pharmaceuticals, INCY, NBIX, VRTX, Sage Therapeutics, and represent 42.56% of Bb Biotech Ag's stock portfolio.
- Added to shares of these 10 stocks: Crispr Therapeutics Ag (+$28.95M), Audentes Therapeutics Inc Com stock (+$23.42M), NKTR (+$21.49M), Myokardia (+$20.15M), Intercept Pharmaceuticals In (+$13.56M), SGMO (+$12.40M), Kezar Life Sciences Inc (+$7.13M), Agios Pharmaceuticals (+$6.74M), ALNY (+$5.58M), Esperion Therapeutics (+$5.22M).
- Started 2 new stock positions in Homology Medicines Inc, Crispr Therapeutics Ag.
- Reduced shares in these 7 stocks: Ionis Pharmaceuticals (-$82.50M), , INCY (-$16.20M), VRTX (-$12.96M), GILD (-$12.35M), CELG (-$9.80M), Akcea Therapeutics Inc equities.
- Sold out of its positions in REGN.
- Bb Biotech Ag was a net seller of stock by $512647.
- Bb Biotech Ag has $3.98B in assets under management (AUM), growing by 27.44%.
Companies in the Bb Biotech Ag portfolio as of March 2019 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Ionis Pharmaceuticals | 15.76 | 7.72M | -11% | 81.17 |
| Incyte Corporation (INCY) | 7.83 | 3.62M | -4% | 86.01 |
| Neurocrine Biosciences (NBIX) | 7.46 | 3.37M | 88.10 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.01 | 1.30M | -5% | 183.95 |
| Sage Therapeutics | 5.50 | 1.38M | 159.05 | |
| Celgene Corporation (CELG) | 5.22 | 2.20M | -4% | 94.34 |
| Agios Pharmaceuticals | 5.05 | 2.98M | +3% | 67.44 |
| Alexion Pharmaceuticals (ALXN) | 4.47 | 1.31M | 135.18 | |
| Alnylam Pharmaceuticals (ALNY) | 3.83 | 1.63M | +3% | 93.45 |
| Esperion Therapeutics | 3.56 | 3.52M | +3% | 40.15 |
| Radius Health | 3.40 | 6.78M | 19.94 | |
| Halozyme Therapeutics (HALO) | 3.37 | 8.32M | 16.10 | |
| Argenx Se | 2.84 | 904739 | +2% | 124.84 |
| Moderna Inc | 2.45 | 4.79M | 20.35 | |
| Myovant Sciences | 2.16 | 3.60M | 23.87 | |
| Intercept Pharmaceuticals In | 1.96 | 696976 | +21% | 111.86 |
| Gilead Sciences (GILD) | 1.87 | 1.14M | -14% | 65.01 |
| Nektar Therapeutics (NKTR) | 1.71 | 2.02M | +46% | 33.60 |
| Exelixis (EXEL) | 1.70 | 2.83M | 23.80 | |
| Akcea Therapeutics Inc equities | 1.69 | 2.38M | 28.33 | |
| Myokardia | 1.65 | 1.26M | +44% | 51.99 |
| Macrogenics | 1.54 | 3.40M | +3% | 17.98 |
| Wave Life Sciences Ltd shs | 1.43 | 1.47M | 38.85 | |
| Voyager Therapeutics | 1.38 | 2.87M | 19.14 | |
| Audentes Therapeutics Inc Com stock | 1.34 | 1.37M | +78% | 39.02 |
| Alder Biopharmaceuticals | 0.95 | 2.77M | 13.65 | |
| Crispr Therapeutics Ag | 0.73 | 810462 | NEW | 35.72 |
| Scholar Rock Hldg Corp | 0.70 | 1.48M | +15% | 18.79 |
| Intra Cellular Therapies | 0.67 | 2.20M | 12.18 | |
| Sangamo Biosciences (SGMO) | 0.64 | 2.65M | +96% | 9.54 |
| Kezar Life Sciences Inc | 0.54 | 1.22M | +49% | 17.74 |
| G1 Therapeutics | 0.28 | 671925 | 16.60 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.15 | 2.30M | 2.65 | |
| Novavax (NVAX) | 0.12 | 8.33M | 0.55 | |
| Homology Medicines Inc | 0.06 | 91336 | NEW | 27.73 |
Download CSV 
Past 13F-HR SEC Filings by Bb Biotech Ag
- Bb Biotech Ag 2018 Q4 filed Feb. 12, 2019
- Bb Biotech Ag 2018 Q3 filed Nov. 9, 2018
- Bb Biotech Ag 2018 Q2 filed Aug. 9, 2018
- Bb Biotech Ag 2018 Q1 filed May 8, 2018
- Bb Biotech Ag 2017 Q4 filed Feb. 14, 2018
- Bb Biotech Ag 2017 Q3 filed Nov. 13, 2017
- Bb Biotech Ag 2017 Q2 filed Aug. 11, 2017
- Bb Biotech Ag 2017 Q1 filed May 10, 2017
- Bb Biotech Ag 2016 Q4 filed Feb. 14, 2017
- Bb Biotech Ag 2016 Q3 filed Nov. 10, 2016
- Bb Biotech Ag 2016 Q2 filed Aug. 12, 2016
- Bb Biotech Ag 2016 Q1 filed May 12, 2016
- Bb Biotech Ag 2015 Q4 filed Feb. 9, 2016
- Bb Biotech Ag 2015 Q3 filed Nov. 12, 2015
- Bb Biotech Ag 2015 Q2 filed Aug. 12, 2015
- Bb Biotech Ag 2015 Q1 filed May 14, 2015
- Bb Biotech Ag 2014 Q4 filed Feb. 12, 2015
- Bb Biotech Ag 2014 Q3 filed Nov. 13, 2014
- Bb Biotech Ag 2014 Q2 filed Aug. 7, 2014